Trademark Search in Canada

ARTELAC REBALANCE

View On IC.GC.CA

REGISTERED

on 16 Sept 2024

Last Applicant/ Owned by

BAUSCH & LOMB INCORPORATED

1400 N. Goodman StreetRochester, NY 14609

Serial Number

2000333 filed on 10^th Dec 2019

Registration Number

TMA1255948 registered on 16^th Sept 2024

Registration expiry Date

16^th Sept 2034

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

ARTELAC REBALANCE

Trademark usage description

ophthalmic pharmaceuticals, namely, eye drops, solutions, gels and ointments for the treatment of eye infection, inflammation and other eye conditions Read More

Classification Information

Class [005]
Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels and ointments for the treatment of eye infection, inflammation and other eye conditions.

Classification kind code

Mark Details

Serial Number

2000333

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 190 on 16^th Sept 2024	Registration Pending
Submitted for opposition 55 on 16^th Sept 2024	Registered
Submitted for opposition 42 on 26^th Jun 2024	Advertised
Submitted for opposition 26 on 3^rd Jun 2024	Approved
Submitted for opposition 27 on 3^rd Jun 2024	Approval Notice Sent
Submitted for opposition 22 on 24^th May 2024	Search Recorded
Submitted for opposition 287 on 6^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 2^th Jan 2020	Formalized
Submitted for opposition 1 on 11^th Dec 2019	Created
Submitted for opposition 30 on 10^th Dec 2019	Filed

ARTELAC REBALANCE

Classification Information

Class [005]Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels and ointments for the treatment of eye infection, inflammation and other eye conditions.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Ophthalmic pharmaceuticals, namely, eye drops, solutions, gels and ointments for the treatment of eye infection, inflammation and other eye conditions.